Glaxo, Danone Probe Highlights Challenges in China

July 3 (Bloomberg) -- China’s probes of GlaxoSmithKline and Danone highlight challenges for foreign companies in a market where they may be a bigger “prize” for regulators seeking to allay concerns that medicines and foods are unsafe. Stephen Engle reports on Bloomberg Television's "First Up." (Source: Bloomberg)

Tesla 4Q Revenue Lighter Than Analyst Estimates
35:16 - Bloomberg's Scarlet Fu and Cory Johnson report on Tesla earnings for the fourth-quarter. They speak on "What'd You Miss?" (Source: Bloomberg)
  • Deep Dive: Why the Selloff Is Steeper in 5-Year Yield
  • Can Tesla Reverse Its Share Slump?
  • Options Insight: How to Play Texas Instruments